EuRSV

· EuBiologics Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EuRSV, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years [Phase 1]

See pricing